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Summary
Nup98andNup96 are componentsof thenuclear trans-
port machinery and are induced by interferons (IFN).
Nup98 is a constituent of an mRNA export pathway
that is targeted by viruses and regulated by IFN. How-
ever, the role of Nup96 in IFN-related mechanisms
has not been established. To investigate the function
of Nup96 in vivo, we generated Nup96+/2mice that ex-
press low levels of Nup96, as Nup962/2mice are lethal.
The Nup96+/2 mice presented selective alterations of
the immune system, which resulted in downregulation
and impaired IFN a- and g-mediated induction of MHC I
and IFNg induction of MHC II, ICAM-1, and other pro-
teins. Frequency of TCRab+ and CD4+ T cells, which
depends on MHC function, is reduced in NUP96+/2
mice. Upon immunization, Nup96+/2 mice showed im-
paired antigen presentation and T cell proliferation.
Nup96+/2 cells and mice were highly susceptible to
viral infection, demonstrating a role forNup96 in innate
and adaptive immunity.
Introduction
Nuclear pore complex proteins (nucleoporins or Nups)
are constituents of the nuclear pore complex (NPC),
which mediates nuclear entrance and exit of molecules
and is regulated by signaling pathways and viruses
(Bednenko et al., 2003; Fontoura et al., 2005; Rout
et al., 2003; Suntharalingam and Wente, 2003). Although
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Southwestern Medical Center, Dallas, Texas 75390.several nucleoporins are structural components of the
NPC, some Nups, such as Nup98, are more dynamically
associated with the NPC and with the nuclear interior
(Griffis et al., 2002). We have shown that Nup98 and
Nup96 are encoded by the same gene (Fontoura et al.,
1999) and are upregulated by interferons (Enninga et al.,
2002). Studies in yeast and vertebrate cells showed that
both proteins are involved in mRNA export (Dockendorff
et al., 1997; Emtage et al., 1997; Powers et al., 1997; Teix-
eira et al., 1997). In fact, inhibition of mRNA export medi-
ated by the vesicular stomatitis virus (VSV) matrix (M)
protein is reverted by treating cells with interferon or is
partially reverted by overexpression of Nup98/Nup96 (En-
ninga et al., 2002). In addition, we found that the mRNA
export factor Rae1, which is a binding partner of Nup98
and is regulated by IFN, mediates the interaction between
VSV M protein and Nup98 (Faria et al., 2005). These inter-
actions result in inhibition of mRNA export that can be
fully reverted by increased expression of Rae1 (Faria
et al., 2005). Thus, regulation of specific nuclear transport
pathways may constitute a defense mechanism against
viral infection that facilitates expression of antiviral genes.
Nup96 is localized at both sides of the NPC and is
a constituent of the Nup107-160 complex that contains
Nup107, Nup160, Nup133, Nup85, Nup96, Sec13,
Nup43, Nup37, and Seh1 (Belgareh et al., 2001; Fontoura
et al., 1999; Harel et al., 2003; Loiodice et al., 2004;
Walther et al., 2003). This complex has a crucial role
in nuclear pore assembly (Harel et al., 2003; Walther
et al., 2003) and mRNA export (Vasu et al., 2001).
Nup96 interacts with Sec13 (Enninga et al., 2003; Lutz-
mann et al., 2002), which is a NPC protein and a compo-
nent of the COPII-coated vesicles at the endoplasmic
reticulum (Bickford et al., 2004). The Nup96 homolog in
S. cerevisiae is C-Nup145p, which has functions related
to mRNA export and chromatin metabolism (Docken-
dorff et al., 1997; Emtage et al., 1997; Galy et al., 2000;
Teixeira et al., 1997). Recently, a putative homolog of
Nup96 inArabidopsis thaliana was shown to be required
for basal defense and constitutive resistance responses
to pathogens mediated by the resistance (R) gene
(Zhang and Li, 2005).
Based on our previous observation that Nup96 is in-
duced by interferons (Enninga et al., 2002) and that the
Nup98/Nup96 gene is involved in antiviral functions, we
investigated whether Nup96 has a role in immune
response. We have developed the Nup96+/2mice, which
express low levels of Nup96 and analyzed expression
and function of interferon-regulated genes such as
MHC class I, MHC class II, and others. MHC I and MHC
II are key players in immune responses. MHC class I an-
tigens are cell surface glycoproteins constituted of an
a chain and a nonpolymorphic chain (b2 microglobulin)
and are expressed in all nucleated cells (Natarajan
et al., 1999). MHC II antigens are membrane glycopro-
teins composed by two polymorphic a and b chains
that are expressed selectively in antigen-presenting
cells such as macrophages, dendritic cells, and B lym-
phocytes (Hedge et al., 2003). Both MHC class I and
class II are regulated by cytokines, including IFNs,
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LPS, phorbol esters, and concanavalin A (David-Watine
et al., 1990; Hedge et al., 2003). Presentation of antigenic
peptides in the pockets of MHC class I and II is an essen-
tial step for the generation and selection of CD8+ and
CD4+ T lymphocytes, respectively, in the thymus as
well as for the activation of mature T cells in the periph-
eral lymphoid tissue. Therefore, we also investigated
the generation of the main T cell subsets in the thymus
of the Nup96+/2 mice. Furthermore, we have studied
the susceptibility of Nup96+/2 mice to viral infection.
Results
Reduced Levels of Nup96 In Vivo Did Not Show
Gross Pathological Alterations in the Whole Animal
or Defects in Nuclear Structure at the Cellular Level
To study the function of Nup96 in vivo, we attempted
to generate Nup962/2 mice. Nup98 and Nup96 are en-
coded by the same gene. This gene yields several alter-
natively spliced mRNAs that encode precursor proteins
that are autocatalytically proteolysed (Figure 1A) (En-
ninga et al., 2003; Fontoura et al., 1999; Rosenblum
and Blobel, 1999). Therefore, to knock out exclusively
the Nup96 gene, we have knocked in three stop codons
at the 50 end of exon 21 of the Nup98-Nup96 gene (Fig-
ure 1B). In this manner, expression of the unique se-
quence of Nup96 is abolished, and exon 20, which
encodes the 6 kDa polypeptide that is shared by
the Nup98-6 kDa precursor and the amino terminus of
Nup96, is maintained to allow proper expression of the
Nup98-6 kDa precursor and, therefore, of Nup98 (Fig-
ure 1A). No Nup962/2 mice were generated, indicating
that Nup96 is essential. Instead, Nup96 heterozygous
and wild-type mice were born at a normal Mendelian fre-
quency and were genotyped by southern blot analysis
(Figure 1C). Pathological evaluation was performed in
each organ of 2-month-old Nup96+/2mice, and no alter-
ations were observed (data not shown). Immunoblot
analysis showed that the Nup96+/2 mice express low
levels of Nup96 as compared to their wild-type litter-
mates (Figures 1D and 1E). However, the Nup98 levels
in Nup96+/2 mice are similar to the wild-type mice, indi-
cating that disruption of the Nup96 gene did not alter the
biogenesis of Nup98 (Figures 1D and 1E). In addition, the
levels of other nucleoporins such as Sec13 and Nup133,
which are in complex with Nup96 at the NPC, were not
significantly altered in the Nup96+/2 mice (Figure 1E).
Also, the levels of Nup62, which is a constituent of the
central cylinder of the NPC, and actin were not affected
in the Nup96+/2 mice (Figure 1E).
To examine potential defects in nuclear structure due
to low levels of Nup96, we analyzed Nup96+/2 cells by
electronmicroscopy and found no obvious alterations
of the nucleus, including absence of nuclear pore clus-
tering and lack of nuclear envelope abnormalities (Fig-
ure 2A). We have also tested bulk poly(A) RNA nuclear
export (Figure 2B), nuclear import of proteins through
the Kapa/Kapb1 (Figure 2C) and the Kapb2/transpor-
tin1-mediated pathways (Figure 2D), and found that
they occurred similarly in both Nup96+/+ and Nup96+/2
cells. We then assessed the intracellular localization of
nucleoporins by confocal microscopy and showed that
Nup62, Nup98, and the remaining pool of Nup96 wereall localized at the expected sites (Figure 2E). Thus, these
findings indicate that there were no major alterations in
nuclear structure or gross defects in some of the major
nuclear transport pathways. However, these findings
do not exclude potential transport defects of specific
classes of proteins or RNAs, as shown below in Figure 4.
Downregulation of Nup96 In Vivo Induced aDecrease
in the Expression of IFN-Regulated Gene Products
Because Nup96 is induced by interferon-g prior to the
upregulation of other interferon-inducible genes, such
as the MHC class I and class II (Enninga et al., 2002;
Giroux et al., 2003), and that IFN-g is able to facilitate
mRNA export that is blocked by a viral protein, at least
in part through upregulation of the Nup98-Nup96 gene,
we investigated whether Nup96 has any role on the ex-
pression of interferon-g-inducible genes. To test this
possibility, we obtained macrophages and dendritic
cells from spleen and thymus of Nup96+/+ and Nup96+/2
mice and measured MHC class I (H-2Db) and MHC class
II (I-Ab) expression by FACs analysis. We found that both
MHC class I and class II levels are reduced in macro-
phages and dendritic cells from the spleen and thymus
(Figures 3A–3C, 3H, and 3I). In addition, a decrease in
MHC class I and MHC class II levels was also observed in
Tand B lymphocytes fromlymphnodes (datanot shown).
We then tested whether other interferon-induced genes
were altered in macrophages from Nup96+/2 mice.
Figure 1. Targeted Disruption of the Mouse Nup96 Gene Yielded
Nup96 Mice Expressing Low Levels of Nup96
(A) Schematic representation of the Nup98-Nup96 and Nup98-6 kDa
precursor proteins. These precursors undergo autocleavage, which
generates Nup98, Nup96, and a 6 kDa polypeptide.
(B) The exon 21 region of the wild-type allele is depicted at the top.
Shown at the bottom is the mutant allele containing a three-way stop
codon at the 50 end of exon 21 of Nup96 and a Neo cassette up-
stream of exon 21 that was deleted by using the Cre recombinase.
The 30 probe used for Southern blot analysis is indicated.
(C) Southern blot of genomic DNA from Nup96+/+ and Nup96+/2mice
digested with BglI and NcoI and hybridized to a 30 probe shows the
1.4 kb fragment for the wild-type and the 2.2 and 1.4 kb fragments
for the mutant.
(D and E) Immunoblot analysis was performed with tissue extracts
from kidney and liver or with cell extracts from macrophages, using
antibodies against Nup98, Nup96, Nup133, Sec13, Nup62, and actin.
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297Figure 2. Nuclear Structure and Some of the Major Nuclear Transport Pathways Are Not Altered in Cells from Nup96+/2 Mice
(A) Livers from Nup96+/+ and Nup96+/2mice were processed for thin sectioning and observed by electron microscopy. Arrowheads show NPCs.
(B) Oligo-dT in situ hybridization was performed in MEFs from Nup96+/+ and Nup96+/2 mice.
(C and D) (C) Nuclear import assays were performed with NLS I-BSA or MBP-M3-GFP (D) with MEFs from Nup96+/+ and Nup96+/2 mice.
(E) Intracellular localization of Nup98 and Nup96 and of other nucleoporins that are recognized by the mAb414, such as Nup62 and, to a lesser
extent, Nup153, was assessed by immunofluorescence followed by deconvolution and apotome microscopy.In fact, the levels of CD54 (ICAM-1) and CD86 (B7.2),
which are plasma membrane proteins known to be in-
duced by interferon-g, are also reduced in macrophages
expressing low levels of Nup96 (Figures 3E and 3G),
whereas the constitutive levels of CD11b, which is a sur-
face protein that is regulated by IFN, did not change
(Figure 3F). We did not observe any difference on the ex-
pression levels of several plasma membrane proteins
that are not regulated by interferon but are important
in immune response, including CD4, CD8, CD25, and
CD62L (Figure 3J). Altogether, these results indicate
that Nup96 facilitate expression of major interferon-reg-
ulated gene products.
To investigate whether the induction levels of MHC ex-
pression by IFN were also altered in Nup96+/2 mice, we
isolated macrophages from Nup96+/+ and Nup96+/2
mice and stimulated them in vitro with IFN. As shown
in Figure 3D, upregulation of MHC II and MHC I by inter-
feron-g was considerably reduced in Nup96+/2 mice as
compared to Nup96+/+ mice. In addition, IFNa-mediated
induction of MHC I is impaired in Nup96+/2mice, indicat-
ing that the response to both IFNs is defective in thesemice (Figure 3K). IFNg induced expression of CD54
and CD11b, and CD86 was also diminished in macro-
phages of Nup96+/2mice (Figures 3E–3G). Interestingly,
the constitutive levels of CD11b were not altered in
Nup96+/2 macrophages, whereas its induction by inter-
feron-g was abnormal (Figure 3F). Thus, these results
show that macrophages of Nup96+/2mice are refractory
to IFN mediated upregulation of several gene products,
indicating that this effect of IFNs is NUP96 dependent.
The reduced levels of these IFN-regulated proteins
were observed in Nup96 mice with a C57BL/6J and
129/SvEv mixed background as well as with Nup96+/2
mice with a homogenous BALB/c background (data
not shown), indicating that this regulation is not strain
specific but is rather due to lower levels of Nup96.
To investigate whether impaired expression of inter-
feron-regulated gene products occurs at the RNA level,
we quantified specific RNA species derived from total
cell extract or nuclear and cytoplasmic fractions of peri-
toneal macrophages from Nup96+/+ and Nup96+/2mice.
Whereas no difference in the total levels of MHC I, MHC II
(Eb), b2 microglobulin, TAP1, or CIITA mRNAs wereFigure 3. Expression of Interferon-Regulated Proteins Is Altered in Nup96+/2 Mice
(A–I) Macrophages and dendritic cells isolated from thymus and spleen of Nup96+/+ and Nup96+/2 mice were stained with antibodies against
MHC I (H-2Db), MHC II (I-Ab), CD54 (ICAM-1), CD11b, and CD86 and followed by flow cytometry analysis. In IFNg-treated samples, incubation
was performed with 100 U/ml IFNg for 48 hr.
(J) Lymphocytes isolated from Nup96+/+ and Nup96+/2mice were stained with antibodies against CD4, CD8, CD25, and CD62L, and their levels of
expression were analyzed by flow cytometry. Numbers represent the average of the mean fluorescence intensity for the molecule in macro-
phages isolated from a group of mice (n = 7–8). Results represent mean values6SD. Cells were gated initially by light scatter and finally by a mac-
rophage marker (Mac3). *p < 0.05.
(K) Peritoneal macrophages, untreated or treated with IFNsa (50 U/ml) andgas above, were stained with antibodies against MHC I (H-2Db), MHC II
(I-Ab), and CD54 (ICAM-1) and followed by flow cytometry analysis. M.F.I., mean fluorescence intensity. PLN, peripheral lymph nodes. C, control.
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a Specific Class of Immune-Related Genes Is
Altered in Macrophages from Nup96+/2 Mice
Total RNA obtained from nuclear (N) and cy-
toplasmic fractions (C) of peritoneal macro-
phages was amplified and quantified by
real-time RT-PCR using primers specific to
the depicted mRNAs.observed (data not shown), the ratios of nuclear/cyto-
plasmic levels of these mRNAs were partially but signif-
icantly increased in macrophages from Nup96+/2 mice
as compared to Nup96+/+ mice (Figure 4). This partial nu-
clear retention likely contributes to the lower expression
levels of these proteins at the plasma membrane. In con-
trast, RPS11, a-tubulin, and ICAM-1 mRNAs were not
retained in the nucleus, although the levels of ICAM-1
protein at the plasma membrane were lower in macro-
phages from Nup96+/2 mice. It is possible that ICAM-1
protein or cell surface expression is affected at a post-
transcriptional/transport step, possibly due to reduced
expression of other IFNg-induced proteins. Overall,
these results show that nuclear export of specific clas-
ses of mRNAs is disrupted due to lower levels ofNup96. Since these mRNAs encode major players
of immune response, such as MHC I and MHC II,
Nup96+/2 mice may present alterations related to MHC
functions, as we show below.
NUP96+/2 Mice Have Altered Numbers of T and B
Cell Subpopulations in Lymphoid Organs
Since MHC expression is essential not only for immune
responses but also for lymphopoiesis and physiological
interactions between lymphocytes and antigen-present-
ing cells in the periphery, we analyzed the frequency of
T cells, B cells, macrophages, and dendritic cells in a
central lymphoid organ (thymus) as well as in a periph-
eral organ (spleen) (Figure 5A). There is a significant
decrease in TCRab+ T cells and in CD4+ T cells in theFigure 5. Frequency of TCRab+ T Cells and CD4+ T Cells Is Reduced in the Thymus of NUP96+/2Mice, and Frequency of B Cells Is Diminished in
the Spleen of the Nup96+/2 Mice; T Cell Proliferation Is Decreased in Nup96+/2 Mice Immunized with CFA-Emulsified Ovalbumin
(A) Cell subsets were analyzed by flow cytometry using antibodies against CD3 for T lymphocyte, CD19 for B lymphocytes, Mac3 for macro-
phages, and CD11c for dendritic cells. For T cell development study, thymic CD3+ cells were analyzed for expression of either CD4 or CD8.
*p < 0.05. Results are the mean 6 SD (n = 8).
(B) Nup96+/+ and Nup96+/2mice were immunized with OVA emulsified in CFA. Eight days postimmunization, cells from the draining lymph nodes
were cultured in the presence of ovalbumin. T cell proliferation was measured by thymidine incorporation. Results are the mean 6 SD (n = 8).
(C and D) Intracellular staining of IFN-g and IL-4 produced by CD4+ and CD8+ T cells is shown in primary and secondary responses to OVA.
(E) Proliferation of T cells after in vitro stimulation with anti-CD3 mAb is increased in spleen, MLN (mesenteric lymph nodes), and PLN of
NUP96+/2 mice. *p < 0.05. Results are the mean 6 SD (n = 7).
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299Figure 6. Cytokine Production by Splenic T Cells Is Altered in Nup96+/2 Mice; Immunoglobulin Levels Are Slightly but Significantly Reduced
in NUP96+/2 Mice
(A and B) T cells isolated from the spleen of Nup96+/+ and Nup96+/2 mice were stimulated in vitro with ConA for 48 hr. IL-4, IL-2, and IFN-g pro-
duction were measured in the culture supernants by ELISA. *p < 0.05. Results are the mean 6 SD (n = 8).
(C) Intracellular staining of IFN-g and IL-4, produced by CD4+ and CD8+ T cells, is shown in response to 24 hr ConA treatment.
(D and E) Immunoglobulin levels were determined in sera of Nup96+/+ and Nup96+/2 mice by ELISA. *p < 0.05. Results represent mean values6
SD (n = 8).thymus of NUP96+/2 mice, indicating that the defect on
MHC II expression may affect the maturation of CD4+
cells in the thymus. No alterations were observed in im-
mature DN cells or in mature TCRgd+ or in CD8+ T cells.
In the spleen, a significant decrease in the frequency of B
cells was observed. The other analyzed splenic popula-
tions, including resting and activated T cells as well as
antigen-presenting cells, were unchanged.
Reduced Levels of Nup96 Alter
T and B Cell Functions
Since the interaction of MHCs with TCRs is crucial to ac-
tivate T cells, we tested whether the reduced levels of
MHC expression would affect two major T cell functions,
including T cell proliferation and cytokine production by
T cells. Nup96+/+ and Nup96+/2 mice were immunized
with ovalbumin and a potent Th1 adjuvant, Mycobacte-
rium tuberculosis-containing CFA, and specific T cell
proliferation was measured by thymidine incorporation.
We have chosen this type of stimulation because it is
Th1 mediated and induces an IFNg response, which
would probably be affected by the reduced levels of
Nup96. Indeed, the reduced levels of Nup96 yielded
a specific decrease in T cell proliferation (Figure 5B) with-
out change in the production of specific Th1 cytokines,
IFNg, and IL-2 (data not shown). Furthermore, IFN-g-
positive CD4+ T cells were present in lower frequency
in Nup96+/2 cells as compared to Nup96+/+ cells (Fig-
ure 5C). This effect was more significant in the secondary
response to the antigen than in the primary response. No
significant trend was observed in the prevalence of IL-
4-producing CD4+ or CD8+ T cells (Figure 5D). Since
immunization with CFA-emulsified OVA triggers a MHC-
dependent response, these results indicate that presen-
tation of soluble antigen is deficient in Nup96+/2 mice.
Since MHC-dependent T cell proliferation was dimin-
ished in Nup96+/2 mice, we investigated whether this
defect is intrinsic and possibly independent on MHC ex-
pression. Therefore, we performed polyclonal MHC-
independent stimulation of T cells using anti-CD3 mono-
clonal antibody. As shown in Figure 5E, T cells derived
from spleen, mesenteric lymph nodes, and peripheral
lymph nodes showed an increase in T cell proliferation
when stimulated with anti-CD3 antibody. In addition,
nonstimulated control T cells also showed an increased
ability to proliferate (see Discussion). Thus, the observed
decrease in MHC-dependent T cell proliferation is likelya consequence of the diminished levels of MHC expres-
sion in Nup96+/2 mice, as the intrinsic ability of these
cells to proliferate is enhanced.
To further evaluate T cell function, we examined cyto-
kine production by T cells from Nup96+/+ and Nup96+/2
mice. We obtained splenic cells from these mice, stimu-
lated in vitro with ConA for 48 hr, a T cell mitogen, and
measured cytokine production. As shown in Figure 6A,
IFNg production is increased and IL-4 production is re-
duced in Nup96+/2 mice (Figure 6B), suggesting that
these mice are skewed toward a Th1 profile of cytokine
production. Interestingly, CD8+ T cells seem to be im-
portant in this process, since they are the major source
of IFN-g produced after polyclonal stimulation with
ConA for 24 hr (Figure 6C). In contrast, IL-2 production
was not altered (Figure 6A).
Because the production of postswitch immunoglobu-
lins by B cells depends on CD4-T cell help, we tested the
levels of serum Ig in Nup96+/+ and Nup96+/2 mice. We
observed a modest but a significant reduction in the total
Ig levels in Nup96+/2 mice (Figure 6D). This reduction
may be related to the lower number of B cells shown in
Figure 5A and is likely due to a decrease in IgG levels,
since IgM and IgA levels were not altered. When we ex-
amined subclasses of IgG, we observed that IgG1 level
was reduced (Figure 6E) (see Discussion).
Thus, physiological B cell function is slightly impaired
in Nup96+/2 mice, and MHC-dependent T cell functions
are highly altered in these mice. These abnormalities
are reflected in the susceptibility of Nup96+/2 mice to
viral disease upon intranasal infection with VSV (Fig-
ure 7C). In addition, infection of Nup96+/+ and Nup96+/2
cells with VSV showed that Nup96+/2 cells express viral
proteins earlier than Nup96+/+ cells and are more sus-
ceptible to cell death (Figures 7A and 7B). These results
strongly indicate a role for Nup96 in antiviral response
and in both innate and adaptive immunity.
Discussion
We showed here that Nup96 is selectively involved in the
expression of key IFNg-regulated genes. Nup96 is a con-
stituent of the Nup107-Nup160 complex, and experi-
ments that have knocked down members of this com-
plex other than Nup96 showed a major disruption of
NPC assembly yielding defective pores (Boehmer
et al., 2003; Harel et al., 2003; Walther et al., 2003). These
Immunity
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(A and B) Nup96+/+ and Nup96+/2 cells were infected with VSV-GFP, and cell viability was determined as described in Experimental Procedures.
For each condition, 66 images were analyzed. Results represent mean values 6 SD.
(C) Nup96+/+ and Nup96+/2mice were infected with VSV at 105 plaque-forming units and monitored for morbidity (n = 13). Results are the mean6SD.results were obtained at the cellular level. Here, we
chose to use an in vivo system in which Nup96 is ex-
pressed at low levels, but, probably due to redundancies
present in a whole-animal model, nuclear structure was
not disrupted. However, it was possible to select for
prominent defects that cannot be compensated in the
presence of low levels of Nup96 and that are related
to Nup96 function in vivo. We observed a defect in the
immune system of Nup96+/2 mice, which showed
that Nup96 is not only regulated by interferons as we
previously shown (Enninga et al., 2002) but actively par-ticipates in the immune response mediated by inter-
ferons.
Studies that depleted Nup107 in cells either showed
no alteration of Nup96 assembly at the NPC (Boehmer
et al., 2003) or affected Nup96 localization at the NPC
(Walther et al., 2003). This difference may be related to
the degree of depletion achieved in each system. Re-
garding the effect of Nup107 depletion on mRNA export,
Boehmer et al. found a partial inhibition of mRNA ex-
port (Boehmer et al., 2003). Here we showed that, in the
context of a whole-animal model, reduced levels of
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tion of various nucleoporins. In our studies, upon down-
regulation of Nup96 expression, the levels of other con-
stituents of the Nup107-160 complex were not affected,
probably due to redundancies or compensatory mecha-
nisms present in a whole-animal model. However, these
low levels of Nup96 may still have caused NPC abnor-
mality, which was reflected on nucleocytoplasmic trans-
port functions related to mRNA export of key regulators
of immunity but not of bulk mRNA. In addition, we cannot
exclude defects related to intranuclear functions of
Nup96, since a pool of Nup96 is found inside the nucleus
(Enninga et al., 2003; Fontoura et al., 1999). Although we
did not see a significant change in total mRNA levels of
these immune-related genes, we cannot rule out a poten-
tial role for Nup96 in regulating mRNA levels of additional
genes.
The reduced levels of MHC I and MHC II in Nup96+/2
mice pointed to a role for NUP96 in constitutive as well
as IFN-induced expression of these proteins. In the thy-
mus, a selective decrease in TCRab+ and CD4+ T cell
populations (Figure 5A) suggests that impairment in
MHC II expression by thymic macrophages and DCs
have a major role in the development of these popula-
tions. Interestingly, although the expression of MHC
class I is also reduced in thymic macrophages and
DCs (Figure 3), frequency of local CD8+ T cells is not al-
tered (Figure 5A). Probably the lower numbers of mature
CD8+ T cells as compared to CD4+ T cells in the thymus
can explain the fact that defects in T cell development
are detectable only in the latter population. Another pos-
sibility that may account for the reduction in thymic
CD4+ T cells is the poor expression of the costimulatory
molecule CD86 (B7.2) in thymic antigen-presenting cells.
Since CD86 is downmodulated in peritoneal macro-
phages of NUP96+/2 mice, there is a possibility that its
expression is also downregulated in thymic cells. CD86
is usually expressed in the thymus, notably on dendritic
and medulary epithelial cells. Alterations of B7 expres-
sion such as the ones present in CD80/CD86-deficient
mice or CD86-transgenic mice result in profound defects
in the frequency of thymic CD4+ and CD8+ mature T cells
(Yu et al., 2000) . On the other hand, the normal frequency
of CD4+ cells in the spleen (Figure 5A) suggests that pe-
ripheral mechanisms of maintenance of the T cell pool
such as homeostatic proliferation operate to compen-
sate the defect in the thymic output of these cells (Al-
meida et al., 2001).
Another piece of evidence for a role of NUP96 in MHC
expression in these mice is the fact that expression of
MHC I and II by peritoneal macrophages is not properly
upregulated even in the presence of high levels of IFN in
vitro (Figure 3). This result suggests that NUP96 is re-
quired for the inductive effect of IFNs in MHC expres-
sion. Interestingly, spleen cells from NUP96+/2mice pro-
duce significantly higher levels of IFNg when stimulated
in vitro with ConA than control wild-type mice (Figure 6A).
A feedback mechanism may be operating in these mice
to compensate for the defect in MHC expression.
MHC II-dependent immune response to a soluble an-
tigen is also impaired in NUP96+/2 (Figure 5B). This de-
fective response is not due to a constitutive impaired
ability for proliferation, since polyclonally stimulated
splenic T cells as well as nonstimulated T cells fromNUP96+/2 mice showed higher indexes of proliferation
when compared to control mice. Therefore, the impaired
immune response to ovalbumin is likely due to low levels
of MHC II in the Nup96+/2 mice, since antigen presenta-
tion is required for specific immune responses. How-
ever, NUP96+/2 mice have also reduced levels of CD86
and CD54 (ICAM-1) expression. Interaction between
CD28 and the costimulatory molecules of the B7 family,
B7.1 (CD80) and B7.2 (CD86), is a critical step in signaling
for activation and differentiation after antigen-specific
stimulation of T cells (Hathcock et al., 1993; McAdam
et al., 1998). On the other hand, interaction between
T cell-mounted LFA-1 and its ligands, ICAM-1 (CD54), -2,
and -3, is important for T cell surveillance and migration,
T cell-APC crosstalk, and cytotoxic T cell function. LFA-1
coengagement by APC-expressed ICAM-1 triggers T
cell proliferation and IL-2 secretion and induces trans-
membrane signals distinct from those delivered through
the TCR-CD3 complex alone, suggesting a costimulatory
role for this interaction in T cell activation (Zuckerman
et al., 1998). The increased proliferation of T cells from
Nup96+/2mice stimulated via CD3 may be related to ad-
ditional functions of Nups related to regulation of cell
growth. It has been shown that Nup96 is localized in spe-
cific mitotic structures including the spindles and the ki-
netochores (Enninga et al., 2003; Loiodice et al., 2004).
Thus, the function or functions of Nups in mitotic pro-
cesses remain to be elucidated, and this does not
exclude potential effects of Nups on cell growth during
interphase.
Frequency of B cells is also reduced in the spleen of
NUP96+/2mice. Several factors may contribute to main-
tain B cells numbers in normal mice including homeo-
static proliferation (Woodland and Schmidt, 2005) and
the production of IL-4, a B cell growth factor, by T cells
(O’Garra et al., 1986). We observed that downregulation
of Nup96 is associated with a reduction in the IL-4 pro-
duction by splenic T cells upon stimulation with ConA
(Figure 6B). At the same time, IFNg production is signif-
icantly upregulated (Figure 6A). IFNg inhibits prolifera-
tion and differentiation of B cells and also downmodu-
lates IL-4 production by T cells (Reynolds et al., 1987).
Thus, high levels of endogenous IFNg may act directly
on B cell proliferation or may indirectly affect the physi-
ological levels of B cell proliferation by reducing IL-4 pro-
duction in the spleen. This upregulation of IFN-gproduc-
tion may represent a mechanism to compensate for the
downregulation of interferon-induced genes. In fact,
IFNg has also been shown to regulate constitutive ex-
pression of MHC I (Lee et al., 1999).
B cell function is also altered following NUP96 downre-
gulation in vivo. Reduction in serum immunoglobulin
levels in Nup96+/2 mice may be due to a defective inter-
action of B cells with CD4+ T cells, since IgG is the iso-
type affected. Production of IgG antibodies is highly
dependent on germinal center formation, cytokine se-
cretion by activated CD4+ T cells, and CD40-CD40 ligand
interaction (Cerutti et al., 1998; Stavnezer, 2000). MHC
class II downmodulation in NUP96+/2mice may interfere
with IgG production in two levels: (1) by reducing activa-
tion of CD4+ T cells and altering cytokine production by
these cells and (2) and by a direct interference in T-B cell
interaction that occurs via MHC II and costimulatory mol-
ecules. We observed evidence for both mechanisms,
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expression of MHC class II in antigen-presenting cells.
Cytokine production by T cells is also relevant for this
process, since the main isotype affected is IgG1, an im-
munoglobulin that is highly dependent on IL-4 produc-
tion by Th2 cells. We also observed a reduction on the
levels of MHC II expression in B cells of NUP96+/2 mice
(data not shown), suggesting that direct interaction of
these cells with CD4+ T cells may be also altered. In ad-
dition, it is possible that, similar to macrophages, B cells
of NUP96+/2 mice present a defective expression of co-
stimulatory molecules, namely CD86. Studies of mice
rendered deficient in B7.1 and B7.2 have indicated an es-
sential role for B7 costimulation in humoral responses,
including immunoglobulin class switch and germinal
center formation (Borriello et al., 1997).
Importantly, the higher susceptibility of Nup96+/2 cells
and Nup96+/2 mice to VSV infection (Figure 7), together
with impaired responses to type I and type II IFNs (Fig-
ure 3), shows a role for Nup96 in both innate and adaptive
immunity. In addition, a recent work inArabidopsis thali-
ana carrying a mutation in a Toll Interleukin1 receptor-
nucleotide binding-Leu-rich repeat-type R gene has
pointed to a function for Nup96 in basal defense and
constitutive resistance responses to pathogens (Zhang
and Li, 2005). Altogether, these findings underline the im-
portance of nucleocytoplasmic trafficking and/or of ad-
ditional unknown functions of nucleoporins in regulating
immunity.
Experimental Procedures
Generation of Knockin Mice
A 1.6 kb DNA fragment corresponding to a region 0.5–2 kb upstream
of exon 21 of the Nup98/Nup96 gene was generated as short arm and
inserted into the 30 end of a Neo gene cassette, which was flanked by
loxP sites. A three-way stop codon, which stops translation in any
reading frame, was then introduced at the 50 end of exon 21. The
stop codon was created by PCR using primers corresponding to a re-
gion located at the 50end of exon 21 and a region approximately
0.56 kb upstream of exon 21. The PCR product was then cloned
into PspMOI site at the 50 end of the neo gene cassette. A long arm
of 8 kb genomic region was then generated and inserted down-
stream of the introduced stop codons at the 50end of exon 21. The
targeting vector was linearized with NotI and then transfected by
electroporation into 129/SvEv iTL1 embryonic stem cells at InGe-
nious Targeting Laboratory. After selection in G418, surviving colo-
nies were expanded, and PCR analysis was performed to identify
clones that had undergone homologous recombination. The cor-
rectly targeted ES cell lines were microinjected into C57BL/6J blas-
tocysts. The chimeric mice were generated and gave germline trans-
mission of the stop codon introduced at the 50end of the Nup96 gene.
Mice were genotyped by Southern blot analysis. Genomic DNA was
digested with NcoI and BglI, and hybridization was performed using
a probe 600 bp upstream the 30 end of exon 21 of the Nup98/Nup96
gene with the AlkPhos Direct kit (Amersham). Heterozygous mice
were generated with deletion of the Neo cassette by crossbreeding
with Jackson EIIA TG mice (a loxP deleter cre mouse). The presence
of the mutation was confirmed by PCR using a 50 end primer comple-
mentary to the site of the mutation and a 30 end primer 800 bp down-
stream of this site. Mice analyzed in these studies included Nup96+/+
and Nup96+/2mice with 129/SvEv and C57BL/6J strains background
as well as Nup96+/+ and Nup96+/2 mice that were backcrossed to a
homogenous BALB/c strain background. Mice were housed under
specific pathogen-free conditions in our facilities.
Transmission Electron Microscopy
Mice were anesthetized by intraperitoneal injection of an anesthetic
cocktail containing ketamine/xylazine. Livers were perfused withPBS followed by ice-cold 2.5% glutaraldehyde in 100 mM cacodylate
(pH 7.4). Tissues were fixed overnight in the same solution and post-
fixed in 1% osmium tetroxide in the same buffer and then treated
with uranyl acetate, dehydrated in ethanol and propylene oxide,
and embedded in Epon. Grids were analyzed in an electron micro-
scope (100 CX; Jeol Ltd., Tokyo, Japan) operated at 80 kV.
Immunoblot Analysis
Immunoblots were performed with anti-Nup98 (Radu et al., 1995),
anti-Nup96 (Fontoura et al., 1999), anti-Sec13 (Enninga et al.,
2003), or mAb14 antibodies (Davis and Blobel, 1986) as previously
described (Faria et al., 2005).
Oligo-dT In Situ Hybridization, Nuclear Import Assay,
and Deconvolution/Apotome Microscopy
MEFs grown on coverslips were washed in PBS, fixed with electron
microscopy grade formaldehyde, and permeabilized with Triton
X-100 as previously described (Bastos et al., 1996). Oligo-dT in situ
hybridization was performed as previously described (Bastos
et al., 1996). Samples were examined on a Zeiss Axiovert 200M
with Deconvolution and Apotome Systems, Video System, Axio-
vision 4.0. Nuclear import assays were performed as previously
described (Moore and Blobel, 1992). TMBP-M3-GFP or NLS-BSA/
tetramethylrhodamine B isothiocyanate-NLS-bovine serum albumin
was used as substrate (Chook et al., 2002; Moore and Blobel, 1992).
RNA Quantification by Real-Time PCR
Perinoteal macrophages were lyzed for 10 min at 4ºC in a buffer con-
taining 25 mM Tris (pH 7.4), 15 mM NaCl, 12.5 mM MgCl2, 5% su-
crose, 0.7% Igepal, and 1000 U/ml RNAsin. Nuclear fractions were
collected by centrifugation at 1000 3 g for 3 min and supernatants
constituted the cytoplasmic fractions. Total RNA from each fraction
was purified using the PicoPure isolation kit (Arcturus). Quality and
size distribution of RNAs were determined by the Agilent 2100 Bio-
analyzer (Agilent Technologies). RNAs were amplified according to
the Amino Allyl MessageAmp aRNA kit (Ambion). The resulting
cDNA was diluted in water and used in PCR reactions using the iCy-
cler iQ Real-time PCR Detection System (Bio-Rad) according to the
manufacturer’s instructions and as previously described (Chang
et al., 2004).
Antigens
Hen egg ovalbumin (grade III) and Concanavalin A were purchased
from Sigma.
Immunization
Mice were immunized subcutaneously (s.c.) at the base of the tail
with 100 mg OVA emulsified in complete Freund’s adjuvant (CFA)
containing 50 mgMycobacterium tuberculosisH37RA (DIFCO). Eight
days postimmunization, mice were sacrificed, and the draining
lymph nodes (inguinal) were harvested for proliferation and cytokine
assays.
Cell Preparations
Spleen and lymph nodes (inguinal, brachial, and mesenteric) were
removed, and cell suspensions were prepared using a tissue homog-
enizer and gently centrifuged. Spleen cells were depleted of erythro-
cytes by resuspending them in 9 ml of water and immediately adding
1 ml 103 PBS to recover tonicity. Peritoneal macrophages were col-
lected 3 days after injection of 2 ml 3% thioglycolate solution i.p.
Analysis of Cell Markers and Intracellular Cytokines
by Flow Cytometry
Rat FITC-labeled antibodies used for labeling mouse markers were
anti-TCRa, anti-TCRd, anti-CD19, anti-CD11c, anti-Mac3, and anti-
CD11b. Rat PE-labeled antibodies were anti-CD4, anti-CD8a, anti-
H-2kb, anti-I-Ab, anti-CD54, anti-CD11a, anti-CD14, anti-CD16,
anti-CD80, and anti-CD86. Cychrome-labeled anti-CD3 antibody
was also used. Intracellular cytokines were detected in cells labeled
with FITC-labeled CD4 or CD8 antibodies and PE-labeled anti-IFN-g
or anti-IL-4 antibodies. Cells were applied to a FACScan. Cell sub-
sets were also analyzed by their specific cell-surface markers (CD3
for T lymphocyte, CD19 for B lymphocytes, Mac3 for macrophages,
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303and CD11c for dendritic cells). All data were analyzed using Cell-
Quest software.
Measurement of Serum Immunoglobulins
To assess total levels of serum immunoglobulins, mice were bled un-
der anesthesia from the auxiliary plexus, and serum was collected
from blood after 30 min of resting at room temperature and 3 min
centrifugation at 2000 rpm. Levels of isotype-specific Ig in sera
were determined by ELISA.
Cytokine Assays
Cells isolated from spleen (erythrocyte depleted) and lymph nodes
were cultured at 13 107 cells/ml with or without 4 mg/ml Concanav-
alin A (Con A). Supernatants were collected after 48 hr, and cytokine
levels were measured by capture ELISA. For intracellular staining,
primary cultures were stimulated with either ConA for 12 and 24 hr
or OVA for 12 hr in the presence of 10 mg/ml brefeldin A. Cells were
stained for flow cytometry analysis. Secondary response to OVA
was measured by restimulation of primary cultures (kept without bre-
feldin) 12 hr after the first stimulation. Cells were incubated for an-
other 12 hr in the presence of antigen and brefeldin A and subjected
to flow cytometry analysis.
Proliferation Assay
Cultures contained erythrocyte-depleted spleen cells and lymph
node cells from individual mice at 5 3 106 cells/ml were incubated
in 96-well plates (Nunc, Naperville, Illinois) in complete RPMI with
or without 100 mg/ml anti-CD3 monoclonal antibodies (BD-Pharmin-
gen) for 72 hr. [3H thymidine] at 1 mCi/well was added for the last
12 hr of culture, and thymidine incorporation was measured.
Statistical Analysis
Results represent mean values6SD of a group (n = 7–8), and the sta-
tistical significance of differences was determined using ANOVA.
In Vitro and In Vivo Survival Assays
Nup96+/+ and Nup96+/2 MEFs were infected with VSV-GFP at MOIs
of 0, 0.01, 0.1, 1, 5, and 10 for 6, 9, or 24 hr, and cell viability was fol-
lowed by bright-field microscopy, GFP expression, and exclusion of
2 mM ethidium homodimer-1 (Molecular Probes) visualized on 5 ran-
domly picked 1003 microscopic fields. Four hundred images were
processed using the NIH Image J software. For in vivo assays,
mice were infected intranasally with VSV at 105 plaque-forming units
and were monitored for morbidity.
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